Greenwich Rx is voluntarily recalling 10 lots of compounded glutathione injection distributed nationwide after testing indicated that the products may contain elevated levels of bacterial endotoxins, according to a company announcement posted by the U.S. Food and Drug Administration.
The recall covers glutathione 200 mg/mL supplied in 10 mL multidose vials and intended for subcutaneous injection. The affected products were distributed across the United States between June 26 and September 21, 2026.
Lots covered by the recall
The recalled lot numbers are 0060-062426-1, 0060-062726-1, 0060-070926-1, 0060-071426-1, 0060-071426-2, 0060-072026-1, 0060-072726-1, 0060-072926-1, 0060-073126-1 and 0060-080426-1. Their beyond-use dates range from October 2 through November 12, 2026. Patients and health professionals should compare both the lot number and date on the vial with the FDA notice.
Greenwich Rx said consumers should stop using product from the recalled lots and follow the disposal instructions provided with the recall. Anyone who experienced a problem after receiving the product should contact a health professional.
Why elevated endotoxin matters
Injectable products containing excessive endotoxin can cause serious inflammatory reactions, including fever and low blood pressure. In severe cases, exposure can lead to anaphylactic shock or death. The FDA notice said the company had received two reports involving patients who required emergency-department care after the product was administered intravenously, even though the recalled formulation was not intended for intravenous use.
That detail does not change the recall’s scope: all listed lots are being recalled at the consumer level. Patients should not attempt to change the route or dose of an injectable medicine on their own.
Questions about the recall can be directed to Sedgwick at 866-552-4916, Monday through Friday from 8 a.m. to 5 p.m. Eastern, or GreenwichRx7542@sedgwick.com. Adverse events may also be reported through the FDA’s MedWatch program.
For other verified medication and public-health updates, visit AskNovus Health.
Featured image: Diana Polekhina/Unsplash. Image used illustratively; it does not depict the recalled product.
Sources
- U.S. Food and Drug Administration recall notice, posted October 1, 2026.
- FDA MedWatch safety alert, October 1, 2026.
- Houston Chronicle recall report, October 2, 2026.